The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
https://www.lse.co.uk/rns/TILS/b-riley-virtual-neuroscience-investor-conference-xrb2q90xox7ujjm.html
15.30 p.m U.K. time
Moving up already 7% on this news .
Best list is the NASDAQ for the biggest potential as they love pharma stocks. I think peoples views are clouded and cannot see the potential.
Hold and gain as these stocks take off in 2021. If you dont like the stock there is the selling option..
Best Invest will hold them for you and list them in your account. You can sell on the net only by a phone sell.
Great news and milestones on track.for the production to start in June with the plant commission now almost fully complete. On wards and upwards.
https://www.lse.co.uk/rns/POLX/result-of-placing-and-subscription-pdmr-dealings-074jckev1nbaw2k.html
Not happy with such a big holding by Bracco Imaging .
With the amount of sites they have now with preferential low rents, the revenue will be profitable this is excluding the bonus of online business. I have been to escape rooms across Europe starting 6 years ago and the U.k was behind the curve. Quality rooms is what I look for and Escape Hunt is at the top with premium rooms. We are only at the start of this business. The growth is massive.
Great press conference. May be Borus will be accused of ramping LFT.. Now we know the road ahead is part of the plan which is great confirmation. We know they want to place contracts with UK. companies.
We should get an update very soon. From RNS Wed, 23rd Dec 2020 07:00
"We expect to receive feedback from the MHRA (Medicines and Healthcare products Regulatory Agency) on the Clinical Trial Application by February 2021. Dosing of first patients will commence when we have responded to that feedback and received approval to proceed. I look forward to updating the market on the detailed timing in due course."
"significant clinical and commercial value in a chemotherapy market that is expected to grow to $56 billion by 2024."
25,000 shares is 6k . In the noise of deals. Why bother posting.
This is 02-11-2020 old Bloomberg post